236 related articles for article (PubMed ID: 34478688)
1. An insight into crosstalk among multiple signaling pathways contributing to epileptogenesis.
Gautam V; Rawat K; Sandhu A; Kumari P; Singh N; Saha L
Eur J Pharmacol; 2021 Nov; 910():174469. PubMed ID: 34478688
[TBL] [Abstract][Full Text] [Related]
2. Mammalian target of rapamycin (mTOR) inhibition as a potential antiepileptogenic therapy: From tuberous sclerosis to common acquired epilepsies.
Wong M
Epilepsia; 2010 Jan; 51(1):27-36. PubMed ID: 19817806
[TBL] [Abstract][Full Text] [Related]
3. Role of mTOR inhibitors in epilepsy treatment.
Sadowski K; Kotulska-Jóźwiak K; Jóźwiak S
Pharmacol Rep; 2015 Jun; 67(3):636-46. PubMed ID: 25933981
[TBL] [Abstract][Full Text] [Related]
4. Aspects of cAMP Signaling in Epileptogenesis and Seizures and Its Potential as Drug Target.
Mertz C; Krarup S; Jensen CD; Lindholm SEH; Kjær C; Pinborg LH; Bak LK
Neurochem Res; 2020 Jun; 45(6):1247-1255. PubMed ID: 31414342
[TBL] [Abstract][Full Text] [Related]
5. Anticonvulsant and anti-apoptosis effects of salvianolic acid B on pentylenetetrazole-kindled rats via AKT/CREB/BDNF signaling.
Yu X; Guan Q; Wang Y; Shen H; Zhai L; Lu X; Jin Y
Epilepsy Res; 2019 Aug; 154():90-96. PubMed ID: 31112902
[TBL] [Abstract][Full Text] [Related]
6. Differential Regulation of Wnt/β-catenin Signaling in Acute and Chronic Epilepsy in Repeated Low Dose Lithium-Pilocarpine Rat Model of Status Epilepticus.
Rawat K; Gautam V; Sandhu A; Bhatia A; Saha L
Neuroscience; 2023 Dec; 535():36-49. PubMed ID: 37913863
[TBL] [Abstract][Full Text] [Related]
7. The role of mTOR inhibitors in preventing epileptogenesis in patients with TSC: Current evidence and future perspectives.
Schubert-Bast S; Rosenow F; Klein KM; Reif PS; Kieslich M; Strzelczyk A
Epilepsy Behav; 2019 Feb; 91():94-98. PubMed ID: 29941212
[TBL] [Abstract][Full Text] [Related]
8. The mammalian target of rapamycin signaling pathway mediates epileptogenesis in a model of temporal lobe epilepsy.
Zeng LH; Rensing NR; Wong M
J Neurosci; 2009 May; 29(21):6964-72. PubMed ID: 19474323
[TBL] [Abstract][Full Text] [Related]
9. Finding a better drug for epilepsy: the mTOR pathway as an antiepileptogenic target.
Galanopoulou AS; Gorter JA; Cepeda C
Epilepsia; 2012 Jul; 53(7):1119-30. PubMed ID: 22578218
[TBL] [Abstract][Full Text] [Related]
10. mTOR inhibitors as a new therapeutic option for epilepsy.
Curatolo P; Moavero R
Expert Rev Neurother; 2013 Jun; 13(6):627-38. PubMed ID: 23739000
[TBL] [Abstract][Full Text] [Related]
11. Gene expression profiling of a hypoxic seizure model of epilepsy suggests a role for mTOR and Wnt signaling in epileptogenesis.
Theilhaber J; Rakhade SN; Sudhalter J; Kothari N; Klein P; Pollard J; Jensen FE
PLoS One; 2013; 8(9):e74428. PubMed ID: 24086344
[TBL] [Abstract][Full Text] [Related]
12. Pentylenetetrazole-induced seizures cause acute, but not chronic, mTOR pathway activation in rat.
Zhang B; Wong M
Epilepsia; 2012 Mar; 53(3):506-11. PubMed ID: 22242835
[TBL] [Abstract][Full Text] [Related]
13. Role of the mTOR signaling pathway in epilepsy.
Meng XF; Yu JT; Song JH; Chi S; Tan L
J Neurol Sci; 2013 Sep; 332(1-2):4-15. PubMed ID: 23773767
[TBL] [Abstract][Full Text] [Related]
14. Regulation of cell death and epileptogenesis by the mammalian target of rapamycin (mTOR): a double-edged sword?
Zeng LH; McDaniel S; Rensing NR; Wong M
Cell Cycle; 2010 Jun; 9(12):2281-5. PubMed ID: 20603607
[TBL] [Abstract][Full Text] [Related]
15. Activation of mTOR signaling pathway is secondary to neuronal excitability in a mouse model of mesio-temporal lobe epilepsy.
Shima A; Nitta N; Suzuki F; Laharie AM; Nozaki K; Depaulis A
Eur J Neurosci; 2015 Apr; 41(7):976-88. PubMed ID: 25605420
[TBL] [Abstract][Full Text] [Related]
16. Wnt/β-catenin signaling as a potential target for novel epilepsy therapies.
Hodges SL; Lugo JN
Epilepsy Res; 2018 Oct; 146():9-16. PubMed ID: 30053675
[TBL] [Abstract][Full Text] [Related]
17. mTOR inhibition modulates epileptogenesis, seizures and depressive behavior in a genetic rat model of absence epilepsy.
Russo E; Citraro R; Donato G; Camastra C; Iuliano R; Cuzzocrea S; Constanti A; De Sarro G
Neuropharmacology; 2013 Jun; 69():25-36. PubMed ID: 23092918
[TBL] [Abstract][Full Text] [Related]
18. Cilostazol disrupts TLR-4, Akt/GSK-3β/CREB, and IL-6/JAK-2/STAT-3/SOCS-3 crosstalk in a rat model of Huntington's disease.
El-Abhar H; Abd El Fattah MA; Wadie W; El-Tanbouly DM
PLoS One; 2018; 13(9):e0203837. PubMed ID: 30260985
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic role of mammalian target of rapamycin (mTOR) inhibition in preventing epileptogenesis.
McDaniel SS; Wong M
Neurosci Lett; 2011 Jun; 497(3):231-9. PubMed ID: 21354266
[TBL] [Abstract][Full Text] [Related]
20. Mechanistic target of rapamycin (mTOR) in tuberous sclerosis complex-associated epilepsy.
Curatolo P
Pediatr Neurol; 2015 Mar; 52(3):281-9. PubMed ID: 25591831
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
